Rating Update: Stock Rating D-Negative (2/13/24)-Ionis Pharmaceuticals Inc (IONS).
BUSINESS Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy […]